Campbell & Co. Investment Adviser »

Alnylam Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 11k 149.45
2022-09-30 $512k 2.6k 200.16
2022-06-30 $808k 5.5k 145.82
2022-03-31 $466k 2.9k 163.39
2021-09-30 $245k 1.3k 188.46
2018-06-30 $266k 2.7k 98.41
2014-12-31 $645k 6.7k 96.96

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Alnylam Pharmaceuticals

Vanguard Group
FMR
BlackRock
Wellington Management Company
Baillie Gifford & Co
T. Rowe Price Associates
Dodge & Cox
T. Rowe Price Investment Management
Geode Capital Management
Jpmorgan Chase & Co
American Century Companies
Susquehanna International
venBio Select Advisor
Pictet Asset Management Holding SA
Legal & General Group

View all funds holding Alnylam Pharmaceuticals